课题基金 / 基金详情

USE OF A PRIMARY CARE PRACTICE-BASED RESEARCH NETWORK COLLABORATION TO

USE OF A PRIMARY CARE PRACTICE-BASED RESEARCH NETWORK COLLABORATION TO
利用基于初级保健实践的研究网络合作
批准号:
7952073
负责人:
Robert F Williams
金额:
$0.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

Robert F Williams的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Acanthosis Nigricans [AN] is a skin condition thought to be associated with diabetes and diabetes risk factors. AN has been found to be associated with people who are overweight. Most research has found that AN is associated with insulin resistance. However, other studies have not found AN to be an indication for insulin resistance, but rather a predictor of being significantly overweight. The purpose of the study is to look at patients who are of the same ethnicity, age, and weight range, and who have Acanthosis Nigricans [AN] to determine if they are more likely to have diabetes or risk factors for diabetes than patients who do not have AN.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USE OF A PRIMARY CARE PRACTICE-BASED RESEARCH NETWORK COLLABORATION TO
  • 批准号:
    7716621
  • 项目类别:
  • 资助金额:
    $0.68万
  • 财政年份:
    2008
  • 负责人:
    Robert F Williams
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: